From: Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients
Variables | NAFLD (n = 713) | Healthy controls (n = 304) | P value | |
---|---|---|---|---|
 | Without MS (n = 413) | With MS (n = 300) |  |  |
Age (yr) | 45.9 ± 12.1 | 46.3 ± 12.2 | 46.3 ± 10.6 | 0.874 |
Gender (female/male) | 132/281# | 48/252* | 110/194 | <0.001 |
BMI (kg/m2) | 25.9 ± 2.7*# | 26.8 ± 2.5* | 22.8 ± 2.6 | <0.001 |
SBP (mmHg) | 131± 16* | 132 ± 16* | 120 ± 14 | <0.001 |
DBP (mmHg) | 80 ± 11* | 81 ± 11* | 78 ± 10 | <0.001 |
ALT (IU/L) | 26 (7–179)*# | 33 (9–184)* | 17 (6–39) | <0.001 |
AST (IU/L) | 24 (12–103)*# | 26 (14–122)* | 20 (12–38) | <0.001 |
γ-GT (IU/L) | 29 (8–248)*# | 41 (7–236)* | 18 (7–50) | <0.001 |
TG (mmol/L) | 1.32 (0.34–3.74)*# | 2.26 (0.63-21.05)* | 0.97 (0.39–1.70) | <0.001 |
TC (mmol/L) | 4.91 ± 0.91*# | 5.06 ± 1.06* | 4.51 ± 0.63 | <0.001 |
HDL-c (mmol/L) | 1.24 ± 0.34*# | 1.01 ± 0.24* | 1.27 ± 0.28 | <0.001 |
LDL-c (mmol/L) | 2.74 ± 0.57*# | 2.62 ± 0.64* | 2.49 ± 0.44 | <0.001 |
FPG (mmol/L) | 5.21 (3.82–7.52)*# | 5.43 (4.23–16.46)* | 4.76 (3.81–6.08) | <0.001 |
Cr (μmol/L) | 73 (37–104) # | 76 (34–108)* | 70 (40–104) | <0.001 |
UA (μmol/L) | 351 (66–548)*# | 381 (146–547)* | 309 (171–422) | <0.001 |
Amylase (IU/L) | 45 (21–207)*# | 42 (21–102)* | 53 (7–122) | <0.001 |
HbA1C (%) | 5.6 (4.2–6.9)*# | 5.7 (4.6–12.5)* | 5.5 (3.2–6.3) | <0.001 |
HsCRP (mg/L) | 1.4 (0.3–19.4)*# | 1.6 (0.3–15.2)* | 0.9 (0.2–8.8) | <0.001 |
PLT (109/L) | 233 ± 52* | 231 ± 55* | 214 ± 41 | <0.001 |